460 related articles for article (PubMed ID: 22134222)
21. Strain-dependent dysregulation of one-carbon metabolism in male mice is associated with choline- and folate-deficient diet-induced liver injury.
Pogribny IP; Kutanzi K; Melnyk S; de Conti A; Tryndyak V; Montgomery B; Pogribna M; Muskhelishvili L; Latendresse JR; James SJ; Beland FA; Rusyn I
FASEB J; 2013 Jun; 27(6):2233-43. PubMed ID: 23439872
[TBL] [Abstract][Full Text] [Related]
22. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
23. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.
Lim JS; Mietus-Snyder M; Valente A; Schwarz JM; Lustig RH
Nat Rev Gastroenterol Hepatol; 2010 May; 7(5):251-64. PubMed ID: 20368739
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome and non-alcoholic fatty liver disease.
Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
Ann Hepatol; 2009; 8 Suppl 1():S18-24. PubMed ID: 19381120
[TBL] [Abstract][Full Text] [Related]
25. Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet.
Cho SJ; Kim SB; Cho HJ; Chong S; Chung SJ; Kang IM; Lee JI; Yoon IS; Kim DD
J Agric Food Chem; 2016 Jul; 64(27):5598-606. PubMed ID: 27321734
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance in nonalcoholic fatty liver disease.
Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
[TBL] [Abstract][Full Text] [Related]
27. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
Lim S; Taskinen MR; Borén J
Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
[TBL] [Abstract][Full Text] [Related]
28. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
[TBL] [Abstract][Full Text] [Related]
29. Disruption of hepatic one-carbon metabolism impairs mitochondrial function and enhances macrophage activity in methionine-choline-deficient mice.
Eudy BJ; McDermott CE; Fernandez G; Mathews CE; Lai J; da Silva RP
J Nutr Biochem; 2020 Jul; 81():108381. PubMed ID: 32422424
[TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
Manco M
J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
[TBL] [Abstract][Full Text] [Related]
31. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
[TBL] [Abstract][Full Text] [Related]
32. Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline.
Zhu X; Song J; Mar MH; Edwards LJ; Zeisel SH
Biochem J; 2003 Mar; 370(Pt 3):987-93. PubMed ID: 12466019
[TBL] [Abstract][Full Text] [Related]
33. Effects of Nonpurified and Choline Supplemented or Nonsupplemented Purified Diets on Hepatic Steatosis and Methionine Metabolism in C3H Mice.
Syed R; Shibata NM; Kharbanda KK; Su RJ; Olson K; Yokoyama A; Rutledge JC; Chmiel KJ; Kim K; Halsted CH; Medici V
Metab Syndr Relat Disord; 2016 May; 14(4):202-9. PubMed ID: 26881897
[TBL] [Abstract][Full Text] [Related]
34. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency.
Spencer MD; Hamp TJ; Reid RW; Fischer LM; Zeisel SH; Fodor AA
Gastroenterology; 2011 Mar; 140(3):976-86. PubMed ID: 21129376
[TBL] [Abstract][Full Text] [Related]
35. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.
Sozio MS; Liangpunsakul S; Crabb D
Semin Liver Dis; 2010 Nov; 30(4):378-90. PubMed ID: 20960377
[TBL] [Abstract][Full Text] [Related]
36. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.
Gorden DL; Ivanova PT; Myers DS; McIntyre JO; VanSaun MN; Wright JK; Matrisian LM; Brown HA
PLoS One; 2011; 6(8):e22775. PubMed ID: 21857953
[TBL] [Abstract][Full Text] [Related]
37. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
38. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
Musso G; Gambino R; Cassader M
Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
[TBL] [Abstract][Full Text] [Related]
39. Role of folate in nonalcoholic fatty liver disease.
Sid V; Siow YL; O K
Can J Physiol Pharmacol; 2017 Oct; 95(10):1141-1148. PubMed ID: 28460180
[TBL] [Abstract][Full Text] [Related]
40. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
